Welcome to our dedicated page for Cimpress Plc SEC filings (Ticker: CMPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cimpress plc filings document the Irish public company's financial reporting, material events, capital structure and shareholder governance. Recent Form 8-K reports furnish quarterly earnings documents for fiscal periods, record material-event disclosures and describe capital-allocation actions such as ordinary share repurchase authorizations.
Proxy filings for Cimpress cover annual general meeting matters, board reappointments, shareholder voting items and governance procedures. The filing record also provides formal disclosure around material agreements, operating and financial results, ordinary-share capital matters and other events relevant to its web-to-print mass-customization business.
CMPR reported a proposed disposition of Common stock via a Stock Option Exercise to be effected on 05/28/2026. The notice lists 5,009 shares associated with that transaction. The filing also records a prior sale of 22,980 shares on 05/27/2026 for $2,403,590.64.
CMPR filed a Form 144 reporting proposed transactions in Common Stock consisting of planned sales and recent securities issued as payment and purchases. The filing lists specific share amounts tied to equity awards and one open‑market purchase, with transaction dates ranging from 11/15/2024 to 05/15/2026.
Cimpress plc executive Florian Baumgartner, EVP and CEO of Vista, reported routine equity award activity in the form of vesting and exercises of share units into ordinary shares. On May 15, 2026, he exercised awards covering 6,544 ordinary shares through the conversion of restricted share units and performance share units that automatically vested under their existing schedules.
To satisfy tax obligations linked to these vestings, 3,108 ordinary shares were disposed of at $93.25 per share via tax withholding, a non‑market transaction rather than an open‑market sale. Following these transactions, Baumgartner continues to hold a substantial direct position in Cimpress ordinary shares, and no open‑market purchases or sales were reported in this filing.
CIMPRESS plc EVP and CFO Sean Edward Quinn reported compensation-related share activity. On 2026-05-15, he exercised restricted and performance share units to acquire 8,521 ordinary shares at a conversion price of $0.00 per share. To cover tax obligations, 3,463 ordinary shares were withheld at $93.25 per share, a non‑market tax-withholding disposition. Following these transactions, he directly holds 49,159 ordinary shares, reflecting an increase from vested equity awards rather than open-market trading.
Cimpress plc EVP and Chief Technology Officer Wensveen Maarten reported routine equity compensation activity in ordinary shares. On May 15, 2026, he exercised previously granted restricted and performance share units into 6,860 ordinary shares at a conversion price of $0.00 per share. To cover tax obligations, 3,282 shares were disposed of at $93.25 per share through a tax-withholding transaction, rather than an open-market sale. Following the reported transactions, he directly holds 21,534 ordinary shares of Cimpress.
Cimpress plc director Ting Wayne Hsing-Yuan reported routine equity compensation activity involving restricted share units (RSUs). On May 15, 2026, 582 ordinary shares were acquired at a price of $0.00 per share through the automatic vesting and exercise of RSUs, with each RSU converting into one ordinary share. On the same date, 280 ordinary shares were disposed of at $93.25 per share as a tax-withholding disposition to cover tax obligations. Following these transactions, the filing shows direct ownership of 302 ordinary shares. Footnotes explain that the RSU award vests over a four-year period, with 25% vesting initially and 25% vesting yearly thereafter.
Cimpress plc director and CEO Robert S. Keane reported routine equity compensation activity involving performance share units (PSUs) and ordinary shares. On May 15, 2026, PSUs automatically vested based on performance conditions, resulting in the issuance of 13,112 ordinary shares at a conversion price of $0.00 per share through multiple PSU awards.
To cover tax obligations, 4,522 ordinary shares were disposed of at $93.25 per share as a tax-withholding transaction, a non-market sale to the issuer, leaving 82,677 ordinary shares held directly. Keane also reports substantial indirect ownership of Cimpress ordinary shares through several Delaware LLCs and a Delaware investment trust, including 986,785 shares held by Third Delaware 2011, LLC and 780,000 shares held by Second Delaware 2003, LLC.
The filing notes that each PSU represents a commitment to issue one ordinary share upon determination of performance outcomes, with awards vesting over four years, including an initial 25% vesting and subsequent quarterly vesting at 6.25% of the performance-determined amount.
Cimpress plc has agreed to acquire the SAXOPRINT and viaprinto businesses from CEWE Stiftung & Co. KGaA, adding two German operations to its PrintBrothers segment. These businesses generated €89.6 million in revenue in calendar year 2025 with approximately 10% EBITDA margins.
Cimpress expects its net cash outflow to be less than €80 million after anticipated asset sales and is targeting base case returns on capital well in excess of 20%. The company also expects the deal to enhance per-share free cash flow while continuing plans to meaningfully reduce net leverage over the next two fiscal years.
The transaction is subject to customary closing conditions, including antitrust approval, and is expected to close in the first half of Cimpress’ fiscal year 2027, covering July 2026 through December 2026. Leadership of the PrintBrothers segment is expected to co-invest and hold a minority stake in the acquired businesses.
Cimpress plc executive Maarten Wensveen, EVP & Chief Technology Officer, reported an exercise-and-sell transaction in the company’s ordinary shares. On May 5, 2026, he exercised options to acquire 10,000 ordinary shares at an exercise price of $46.20 per share.
That same day, he completed multiple open‑market sales totaling 19,251 ordinary shares at weighted‑average prices with per‑share sale prices ranging from $90.59 to $94.79, according to footnotes. After these transactions, he directly owns 38,546 ordinary shares and holds 50,013 options to purchase additional ordinary shares.
Morgan Stanley Smith Barney LLC filed a Form 144 reporting proposed sales of Common Stock tied to issuer awards and an option exercise. The entry lists planned dispositions including 960 restricted shares, 1,909 performance shares, additional restricted/performance grants totaling 6,382 across 2024–2025 dates, and a 10,000 share stock option exercise on 05/05/2026 for cash.